Medicinal Products

Mysimba

Name Mysimba
Active Substance naltrexone / bupropion
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code A08AA62
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Lista provjere za liječnike prije propisivanja lijeka verzija 1

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/mysimba

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back